- +91 9041090167 |
- +91 9041090198
- hilberthealthcare@gmail.com
- Mon - Sat 10.00 A.M - 6.00 P.M
The Indian pharmaceutical industry is standing at a pivotal juncture where specialised medicine is taking precedence over general wellness. Among the various segments, the PCD Pharma Franchise for the Injectable Range has emerged as one of the most recession-proof and high-margin business models. As healthcare infrastructure expands into Tier-2 and Tier-3 cities, the demand for emergency care and critical care injectables is skyrocketing.
At Hilbert Healthcare, we recognise the critical nature of parenteral formulations. This blog post explores the vast landscape of the injectable market, the benefits of starting a franchise, and how you can leverage our expertise to build a sustainable pharmaceutical empire.
The move from oral solids (tablets and capsules) to injectables (parenterals) is driven by the need for immediate therapeutic action. Whether it is a life-saving antibiotic, a critical care steroid, or a nutritional supplement, injectables offer $100\%$ bioavailability, bypassing the digestive system for instant results.
According to industry reports from the Indian Pharmaceutical Association (IPA), the domestic market is shifting significantly toward value-added generics. Recent market research indicates that the Indian generic injectables market is projected to reach approximately USD 20 billion by 2030.
With a steady Compound Annual Growth Rate (CAGR) of over $9\%$, this segment is outpacing many traditional therapeutic categories. The rise in chronic diseases like diabetes and cardiovascular issues, combined with an increasing number of hospitalisations, ensures that the demand for injectables remains perennial.
Unlike general syrups or tablets, injectables are primarily consumed in institutional settings like:
Multi-specialty Hospitals
Nursing Homes
Critical Care Units (ICUs)
Dialysis Centers
Government Healthcare Tenders
For a PCD Pharma Franchise partner, this means larger order volumes and a more professional business environment. You can stay updated on the latest government healthcare tenders and policy shifts via Pharmabiz, India's leading pharma news portal.
Investing in the injectable segment requires a different mindset compared to the general PCD range. Here is why it is considered a "Gold Mine" for pharma professionals:
Injectables are specialised products. Due to the complexity involved in their manufacturing—requiring sterile environments, high-end filtration, and precise vacuum packaging—the competition is lower than in the tablet segment. This allows franchise partners to enjoy significantly higher profit margins.
Not every pharma company can manufacture high-quality injectables. It requires WHO-GMP certified units and DCGI approvals. By partnering with a reputed firm like Hilbert Healthcare, you enter a niche market where only a few quality players exist.
Hospitals and clinics do not stock injectables for months; they use them daily. This leads to a faster rotation of capital. In the pharma business, "Liquidity is King," and the injectable range provides exactly that.
We offer exclusive Monopoly Rights for our injectable range. This ensures that you are the sole distributor of Hilbert Healthcare’s injectable products in your designated territory, eliminating internal competition and allowing you to focus on market penetration.
To succeed in the PCD Pharma Franchise business, you need a diverse basket of products. Hilbert Healthcare provides an extensive range of parenterals across multiple therapeutic segments.
These are the backbone of hospital treatments. Our range includes:
Ceftriaxon & Sulbactam (Ceficheck S)
Piperacillin & Tazobactam
Meropenem
Amoxicillin & Clavulanic Acid
Used in trauma centers and ICUs to stabilise patients:
Pantoprazole Injections (Hipan 40mg) - Essential for managing acidity and GI issues in hospitalised patients.
Dexamethasone & Methylprednisolone - Potent steroids for inflammatory conditions.
Vital for post-operative recovery and chronic deficiencies:
Methylcobalamin (Vitamin B12)
Iron Sucrose
Cholecalciferol (Vitamin D3)
In the injectable range, there is zero room for error. Even a microscopic impurity can lead to severe adverse reactions. At Hilbert Healthcare, quality is not an act; it is a habit.
WHO-GMP Collaboration: All our injectables are manufactured in state-of-the-art facilities that adhere to World Health Organisation (WHO) and Good Manufacturing Practice (GMP) standards.
Sterile Manufacturing: We use advanced Aseptic Filling technologies to ensure the product remains free from pyrogens and microorganisms.
DCGI Approved Molecules: We only deal in molecules approved by the Central Drugs Standard Control Organisation (CDSCO), ensuring legal compliance and patient safety.
If you are looking to start your own business with Hilbert Healthcare, follow these simple steps:
Identify the number of hospitals and clinics in your area. You can refer to the Department of Pharmaceuticals (Govt. of India) for insights into domestic manufacturing trends and regional healthcare growth.
To legally operate a pharma franchise in India, you need:
Drug License (DL): Wholesale drug license from the state authority.
GST Registration: Necessary for tax compliance and inter-state trade.
Select a range of at least 15-20 injectable products from our catalogue to ensure you have a solution for every doctor's needs.
Discuss the availability of your preferred district for monopoly rights with our sales team.
We believe our growth is tied to your success. Therefore, we provide comprehensive support to all our associates:
Promotional Inputs: High-quality visual aids, product glossaries, and MR Bags.
Timely Delivery: A robust logistics network ensuring zero "Out of Stock" scenarios.
Affordable Pricing: Keeping rates competitive to ensure your profitability while offering value to hospitals.
Success in the injectable segment requires a specialised approach:
Hospital Empanelment: Aim to get your products listed in the hospital pharmacy (Rate Contract). This ensures a steady flow of orders.
Focus on Emergency Rooms (ER): Since injectables are emergency medicines, building relationships with ER heads and Anesthesiologists is key.
Secondary Sales Focus: Don't just stock the chemist; ensure the stock is moving by following up on doctor prescriptions.
CME Sponsorship: Participate in local medical seminars or CMEs (Continuing Medical Education) to increase brand visibility among specialists.
The PCD Pharma Franchise for the Injectable Range is a service to the healthcare sector. By providing high-quality, life-saving medicines, you build a reputation that lasts a lifetime. Hilbert Healthcare invites you to join our journey towards excellence.
Website: www.hilberthealthcare.in
Address: S.C.F 439, 1st & 2nd Floor, Motor Market, Manimajra (Chandigarh)-160101
Email: hilberthealthcare@gmail.com
Phone: +91-9041090198
1. What is the minimum investment required? An initial investment of ₹50,000 to ₹1,00,000 is usually sufficient.
2. Do I need previous experience in pharma? While beneficial, it is not mandatory if you have a strong sales mindset.
3. Is there a monthly target? We believe in collaborative growth and work with you to set realistic goals rather than rigid targets.
 (1).jpg)